Literature DB >> 21349772

Pre-eclampsia: Risk factors and causal models.

Lill Trogstad1, Per Magnus, Camilla Stoltenberg.   

Abstract

Pre-eclampsia is a disease of many risk factors and theoretical speculations. It is, for unknown reasons, more prevalent among primiparous women. Some observations show that a change of sexual partner before the next pregnancy increases the risk, but this association disappears when correction is made for time interval since the last birth. Risk factors may be pregnancy-specific, such as twinning or mole, whereas others are linked to the woman, such as obesity and diabetes. Genetic risk factors are being searched for, but as yet with relatively little success. A previous pregnancy complicated by pre-eclampsia is probably the strongest risk factor. For practical purposes, women at increased risk can be identified and should be followed closely. No effective primary preventative action is available. Prevention of the serious consequences of pre-eclampsia still relies on early detection of increases in blood pressure and proteinuria.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21349772     DOI: 10.1016/j.bpobgyn.2011.01.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  35 in total

Review 1.  Association of microparticles and preeclampsia.

Authors:  Fabiana K Marques; Fernanda M F Campos; Lirlândia P Sousa; Andréa Teixeira-Carvalho; Luci M S Dusse; Karina B Gomes
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

2.  Decreased Risk of Preeclampsia After the Introduction of Universal Voucher Scheme for Antenatal Care and Birth Services in the Republic of Korea.

Authors:  Seung-Ah Choe; Hye Sook Min; Sung-Il Cho
Journal:  Matern Child Health J       Date:  2017-01

Review 3.  Mechanisms and management of hypertension in pregnant women.

Authors:  Catherine M Brown; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

Review 4.  Mouse is the new woman? Translational research in reproductive immunology.

Authors:  David A Clark
Journal:  Semin Immunopathol       Date:  2016-01-18       Impact factor: 9.623

5.  Euglycemic hyperinsulinemia increases blood pressure in pregnant rats independent of placental antiangiogenic and inflammatory factors.

Authors:  Ana C Palei; Frank T Spradley; Joey P Granger
Journal:  Am J Hypertens       Date:  2013-08-16       Impact factor: 2.689

6.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

7.  Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.

Authors:  Anne P Starling; Stephanie M Engel; David B Richardson; Donna D Baird; Line S Haug; Alison M Stuebe; Kari Klungsøyr; Quaker Harmon; Georg Becher; Cathrine Thomsen; Azemira Sabaredzovic; Merete Eggesbø; Jane A Hoppin; Gregory S Travlos; Ralph E Wilson; Lill I Trogstad; Per Magnus; Matthew P Longnecker
Journal:  Am J Epidemiol       Date:  2014-02-20       Impact factor: 4.897

Review 8.  Drug treatment of hypertension in pregnancy.

Authors:  Catherine M Brown; Vesna D Garovic
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

Review 9.  Matrix metalloproteinases as drug targets in preeclampsia.

Authors:  Ana C T Palei; Joey P Granger; Jose E Tanus-Santos
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

10.  Persistent organochlorines and hypertensive disorders of pregnancy.

Authors:  David A Savitz; Mark A Klebanoff; Gregory A Wellenius; Elizabeth T Jensen; Matthew P Longnecker
Journal:  Environ Res       Date:  2014-04-16       Impact factor: 6.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.